Clinical Trials Logo

Ventricular Dysfunction, Left clinical trials

View clinical trials related to Ventricular Dysfunction, Left.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05529654 Enrolling by invitation - Clinical trials for Left Ventricular Dysfunction

IMpella-Protected cArdiaC Surgery Trial (IMPACT)

IMPACT
Start date: September 21, 2023
Phase: N/A
Study type: Interventional

The purpose of this Trial is to demonstrate the safety and effectiveness of the use of Impella 5.5 in high-risk cardiac surgery patients, with the overall aim to evaluate if using Impella 5.5 with SmartAssist (Impella 5.5) peri-operatively improves early hemodynamics, end-organ function and clinical outcomes in patients with severely reduced LV function undergoing cardiac surgery.

NCT ID: NCT03701997 Enrolling by invitation - Clinical trials for Ventricular Dysfunction

Registry to Monitor Berlin Heart EXCOR® Pediatric VAD as a Bridge to Cardiac Transplantation.

Start date: October 15, 2018
Phase:
Study type: Observational [Patient Registry]

The purpose of this post market surveillance is to continue monitoring the safety and effectiveness of the Berlin Heart EXCOR® Pediatric. This surveillance includes an "all-comers" prospective cohort of pediatric (<22 years of age) patients implanted according to the IFU with the EXCOR® Pediatric.

NCT ID: NCT03352648 Enrolling by invitation - Heart Failure Clinical Trials

CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry (DERIVATE)

DERIVATE
Start date: January 2007
Phase:
Study type: Observational

The DERIVATE study was conceived to integrate the information resulted from clinical data, transthoracic echocardiography, and cardiac magnetic resonance (CMR) imaging to provide a more reliable risk stratification in patients affected by heart failure (HF) and worthy of prophylactic implanted cardioverter defibrillator (ICD) therapy. The main purposes of this multicenter registry are to: 1) determine CMR findings, and specifically late gadolinium enhancement (LGE) features, T1 mapping, and extracellular volume (ECV) that predict sudden cardiac death (SCD) and ventricular arrhythmia; 2) provide a comprehensive clinical and imaging score that effectively improves the selection of patients who deserve a prophylactic ICD therapy; 3) evaluate the contribution of machine learning to predict major adverse cardiac events (MACE) as compared to standard clinical scores.

NCT ID: NCT01674699 Enrolling by invitation - Clinical trials for Severe Isolated Left Ventricular Dysfunction

Berlin Heart EXCOR Pediatric Post Approval Study

Start date: August 2012
Phase: N/A
Study type: Observational

The purpose of this post-approval study of the EXCOR® Pediatric VAD is to evaluate whether safety and outcomes of the device use in the commercial setting are comparable to the safety and outcomes of the device use in the IDE study.